Physician
Internal Medicine
Dr. Julie G. Beitz, MD
|
|
Give Review
Dr. Julie G. Beitz is an expert in the field of Internal Medicine. Julie Beitz has written publications. He has 22 publications published with PubMed. The lastest publication is: 'Protocol design considerations that relate to demonstrating the safety and effectiveness of chemopreventive agents.'
Publications
- The US Food and Drug Administration's registry of patients with pergolide-associated valvular heart disease.
- Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience.
- Depression and suicide in patients treated with isotretinoin.
- Pregnancy and pregnancy rates in association with isotretinoin (Accutane).
- Quality-of-life end points in oncology drug trials.
- Protocol design considerations that relate to demonstrating the safety and effectiveness of chemopreventive agents.
- Spontaneous reports of thrombocytopenia in association with quinine: clinical attributes and timing related to regulatory action.
- Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
- Trial endpoints for drug approval in oncology: Chemoprevention.
- GI events leading to death in association with celecoxib and rofecoxib.
- Changes in ciprofloxacin utilization as shown in a large pharmacy claims database: effects of proximity to criminal anthrax exposure in October 2001.
- Aseptic meningitis associated with rofecoxib.
- Use of a spontaneous adverse drug events database for identification of unanticipated drug benefits.
- Predictive value of preclinical toxicology studies for platinum anticancer drugs.
- Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective.
- Renal failure associated with the use of celecoxib and rofecoxib.
- Abuse, dependence, or withdrawal associated with tramadol.
- Topiramate-associated secondary angle-closure glaucoma: a case series.
- Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozin.
- Deaths associated with inappropriate intravenous colchicine administration.
- An analysis of reports of depression and suicide in patients treated with isotretinoin.
Schools
Columbia University College of Physicians And Surgeons
Doctors Specialties
- Internal Medicine
Accepted Insurances
Helpful Reviews
Similar Doctors
|
|
Dr. Thomas L. Richie, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Hugo G. Graziani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Soophi Tajik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary E. Wright, MD |
|
|
Dr. Milton S. Grossman, MD |
|
|
Dr. Luis A. Gonzalez, MD |
|
|
Dr. Anuradha A. Arun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Loveen J. Puthumana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joanna W. Ku, MD |
|
|
Dr. Ira J. Berkower, MD |
|
|
Dr. O'Dene H. Lewis, MD |